LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Ranch Cardiologist Performs New Surgery
News | 03. 26. 2009
FlowCardia
Ranch cardiologist performs new surgery.
